Therapeutic strategies with bacterial toxins like IL13PE38QQR (Pseudomonas Exotoxin), IL13DT (Diphtheria toxin) and IL13 linked nanovesicles were demonstrated to selectively target and eliminate GBM tumors leading to increased survival of the tumor bearing mice. The gene discussed is IL13; the disease is neoplasm.